Drugs / Flublok Quadrivalent Influenza Vaccine
last change May 2015 re-read 2 minutes ago

Flublok Quadrivalent Influenza Vaccine

Vaccine

Developed for
influenza
Investigated by
Protein Sciences Corporation

Trials 1 · a red edge is where a trial was stopped

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02285998 Oct 2014 → May 2015 influenza Protein Sciences Corporation Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Flublok Quadrivalent Influenza Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02285998
Modality Vaccine “Biological: Flublok Quadrivalent Influenza VaccineNCT02285998
Route Intramuscular Intramuscular injection of vaccine” NCT02285998